🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Intensive insulin therapy using multiple daily injections (MDI) constitutes...
Status
Unknown
Location
Institute for Clinical and Experimental Medicine
Start Date
2021-07
Trial ID
NCT04945070
Treatments Being Tested
Glucagon-like peptide-1 receptor agonists (GLP-1RA) are powerful second-lin...
Status
Unknown
Location
Servizio di Diabetologia UOC Medicina Generale
Start Date
2018-12-19
Trial ID
NCT03959865
BEYOND represents an open-label, parallel, three-arm randomized controlled ...
Status
Completed
Location
Unit of Endocrinology and Metabolic Diseases
Start Date
2019-11-27
Trial ID
NCT04196231
Treatments Being Tested
Primary Objective: * To demonstrate the superiority of Soliqua 100/33 vers...
Status
Terminated
Location
Investigational Site Number 8400072
Start Date
2018-02-20
Trial ID
NCT03434119
Treatments Being Tested
The investigators aimed to compare efficacy and safety of IGlarLixi and ins...
Status
Unknown
Location
Chungbuk National University Hospital
Start Date
2020-05-26
Trial ID
NCT04893148
Treatments Being Tested
This was a parallel-group treatment, Phase 3, randomized, 2-arm study that ...
Status
Completed
Location
Investigational Site Number : 1560008
Start Date
2022-07-07
Trial ID
NCT05413369
Treatments Being Tested
This is a single-center, randomized, open-label, controlled clinical trial ...
Status
Active Not Recruiting
Location
Department of Endocrinology, the Affiliated Drum Tower Hospital of Nanjing University Medical School
Start Date
2025-03-29
Trial ID
NCT07274644
Treatments Being Tested
Primary Objectives: The co-primary objective of this study is: * To demon...
Status
Completed
Location
Investigational Site Number 1560001
Start Date
2019-02-15
Trial ID
NCT03798054
This is a randomized, 12-week, open-label, active-controlled, parallel grou...
Status
Unknown
Location
Division of Endocrinology and Metabolism, Department of Medicine, Taipei Veterans General Hospital
Start Date
2022-09-28
Trial ID
NCT05591391
Treatments Being Tested
Primary Objective: To demonstrate the superiority of the insulin glargine/...
Status
Completed
Location
Investigational Site Number 8400064
Start Date
2016-07-06
Trial ID
NCT02787551